Skip to content. | Skip to navigation

Press
>
Vetter’s US site successfully manufactures batches on new clinical syringe filling line

Vetter’s US site successfully manufactures batches on new clinical syringe filling line

Additional storage expansion strengthens the facilities’ ability to meet increased customer demand in prefilled syringes

Skokie, Illinois, USA: December 13, 2016 – Vetter, a leading international contract development and manufacturing organization (CDMO) that specializes in aseptic filling for its (bio-)pharmaceutical customers, has announced today that its new clinical syringe line has already manufactured for its customers a double digit number of batches for use in early clinical trials. The line is part of growth expansion activities that have been undertaken at its Skokie facility to help satisfy growing customer demand. It also includes an increase in storage that is designed to help manage the continued growth in syringe fills and overall larger batch sizes.